Ensysce Biosciences, Inc. (ENSC) Stock Forecast
ENSC analyst forecast
as of October 18, 2026- Analyst consensus
- —
- Price target
- $8.25 average of analyst targets
- Upside to target
- +1,492.7% from the latest close
- Next earnings
- November 13, 2026 EPS estimate $-0.19
- 52-week range
- $0.25 – $2.55
ENSC price target
The average of analyst 12-month price targets compared with the latest close and the 52-week range.
ENSC earnings per share estimates
| Period | Average | Low | High | Year ago | Growth | Analysts |
|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | −$0.19 | −$0.19 | −$0.19 | −$1.29 | +85.3% | 1 |
| Current fiscal year (2026) | −$1.09 | −$1.09 | −$1.09 | −$3.98 | +72.6% | 1 |
| Next fiscal year (2027) | −$0.05 | −$0.05 | −$0.05 | −$1.98 | +94.4% | 1 |
Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.
ENSC revenue estimates
| Period | Average | Low | High | Growth | Analysts |
|---|---|---|---|---|---|
| Current quarter (Sep '26) | $1.2M | $1.2M | $1.2M | +143.4% | 1 |
| Current fiscal year (2026) | $4.6M | $4.6M | $4.6M | −9.2% | 1 |
| Next fiscal year (2027) | $0 | $0 | $0 | −65.8% | — |
ENSC EPS: reported and forecast
Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.
ENSC revenue: reported and forecast
ENSC EPS estimate revisions
| Period | 90 days ago | 60 days ago | 30 days ago | 7 days ago | Now | Change (90 d) | Revisions (30 d) |
|---|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | −$0.69 | −$0.49 | $0.09 | $0.04 | −$0.19 | −72.5% | 1 up · 0 down |
| Current fiscal year (2026) | −$3.54 | −$1.98 | −$1.53 | −$1.27 | −$1.09 | −69.2% | 1 up · 0 down |
| Next fiscal year (2027) | $0.00 | $0.00 | $0.00 | −$0.11 | −$0.05 | — | 0 up · 0 down |
How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.
ENSC earnings surprises
Reported EPS vs the consensus estimate for the last 12 quarters; ENSC beat in 9 of 12.
What analysts expect from ENSC
The average price target is $8.25, 1,492.7% above the latest close of $0.52. Analysts expect earnings of −$1.09 per share for 2026, +72.6% from a year earlier. For 2027 the average estimate is −$0.05 per share. Ensysce Biosciences beat the EPS estimate in 9 of the last 12 quarters.
Related: ENSC income statement, ENSC key metrics, ENSC chart. See the ENSC stock overview for the latest quote and news.
ENSC forecast FAQ
What is Ensysce Biosciences's price target?
The average analyst price target for Ensysce Biosciences is $8.25, 1,492.7% above the latest close of $0.52.
What is Ensysce Biosciences's EPS forecast?
Analysts forecast −$1.09 per share for 2026 (range −$1.09 to −$1.09); for 2027 the estimate is −$0.05.
What is Ensysce Biosciences's revenue forecast?
The average revenue estimate for 2026 is $4.6 million, growth of −9.2%.
When does Ensysce Biosciences report earnings?
Ensysce Biosciences is expected to report results for the quarter ending September 30, 2026 on November 13, 2026; the EPS estimate is $-0.19.
Does Ensysce Biosciences usually beat earnings estimates?
Ensysce Biosciences reported EPS at or above the analyst estimate in 9 of the last 12 quarters.